Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | PGR | P06401 | 2/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | HRH1 | P35367 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384880 | 1.00 | HPGD (0.59) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL380370 | 0.96 | LMNA (0.55) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL29483466 | 0.96 | LMNA (0.55) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL4194204 | 0.94 | HPGD (0.58) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL29384629 | 0.94 | HPGD (0.58) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL93611 | 0.94 | HPGD (0.58) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL38659958 | 0.94 | HPGD (0.58) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL27590735 | 0.93 | HTT (0.59) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL27708180 | 0.93 | HTT (0.59) | HPGDMAPK1LMNAHTTCYP1A2 | |
| SCHEMBL14540385 | 0.91 | POLB (0.49) | HPGDMAPK1LMNAHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000813-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | BIOCOAT INCORPORATED (US) | 2026-01-01 | — | — | US | claimed |
| US-12037560-B2 | UV cure topcoatings for medical devices | BIOCOAT, INCORPORATED (US) | 2024-07-16 | — | — | US | claimed |
| EP-4370498-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | Biocoat, Incorporated (US) | 2024-05-22 | — | — | EP | claimed |
| CN-117991591-A | Photosensitive resin composition, photosensitive laminate, method for forming resist pattern, and use thereof | 杭州福斯特电子材料有限公司 | 2024-05-07 | — | — | CN | claimed |
| US-11578286-B2 | UV cure basecoatings for medical devices | BIOCOAT, INCORPORATED (US) | 2023-02-14 | — | — | US | claimed |
| US-20230027324-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2023-01-26 | — | — | US | claimed |
| WO-2023287638-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | BIOCOAT, INCORPORATED (US) | 2023-01-19 | — | — | WO | claimed |
| US-20220280412-A1 | POLYMER COATING AGENT HAVING CONCURRENTLY EXCELLENT WATER AND OIL REPELLENT PROPERTIES AND COSMETIC COMPOSITION COMPRISING SAME SHOWING EXCELLENT MAKE-UP PERSISTENCY | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-09-08 | — | — | US | claimed |
| US-20220275300-A1 | UV Cure Basecoatings For Medical Devices | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2022-09-01 | — | — | US | claimed |
| EP-4048332-A1 | UV CURE COATINGS FOR MEDICAL DEVICES | Biocoat, Inc. (US) | 2022-08-31 | — | — | EP | claimed |
| EP-0758314-A1 | COMPOUNDS CONTAINING A MICHAEL-ACCEPTOR, ESPECIALLY MALEIMIDE OR MALEIC ACID DERIVATIVES, DIRECTLY OR INDIRECTLY LINKED TO A CHROMOPHORE AND THEIR USE IN LONG LASTING SUNSCREEN COMPOSITIONS | Vanguard Medica Limited (GB) | 1997-02-19 | — | — | EP | claimed |
| WO-1995030646-A1 | COMPOUNDS CONTAINING A MICHAEL-ACCEPTOR, ESPECIALLY MALEIMIDE OR MALEIC ACID DERIVATIVES, DIRECTLY OR INDIRECTLY LINKED TO A CHROMOPHORE AND THEIR USE IN LONG LASTING SUNSCREEN COMPOSITIONS | VANGUARD MEDICA LIMITED (GB) | 1995-11-16 | — | — | WO | claimed |
| EP-0487293-A2 | Stabilized acrylic fibers and polyurethane elastomer fibers and process for making same | IPPOSHA OIL INDUSTRIES CO. LTD. (JP) | 1992-05-27 | — | — | EP | claimed |
| US-5002979-A | Hyydrogenorganosilicon monomer, organosilicon, fluoroorgano monomer, a hydrophobic monomer and a crosslinking agent | BAUSCH & LOMB INCORPORATED (US) | 1991-03-26 | — | — | US | claimed |
| EP-0211067-B1 | OXYGEN-PERMEABLE LENSES | Bausch & Lomb Incorporated (US) | 1991-03-13 | — | — | EP | claimed |
| EP-0211067-A1 | OXYGEN-PERMEABLE LENSES. | BAUSCH & LOMB (US) | 1987-02-25 | — | — | EP | claimed |
| EP-0209597-A1 | EXTENDED-WEAR LENSES | Bausch & Lomb Incorporated (US) | 1987-01-28 | — | — | EP | claimed |
| EP-0209299-A1 | Copolymers of ethylene and unsaturated ester | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-01-21 | — | — | EP | claimed |
| WO-1986004342-A1 | OXYGEN-PERMEABLE LENSES | BAUSCH AND LOMB INCORPORATED (US) | 1986-07-31 | — | — | WO | claimed |
| WO-1986004343-A1 | EXTENDED-WEAR LENSES | BAUSCH AND LOMB INCORPORATED (US) | 1986-07-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000813-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | WIZ, CDH1, TET1 | HPGD 973/4885MAPK1 3107/4885LMNA 3378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.